Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Innovent reports positive results from two trials of IBI305

NSCLC is a type of epithelial lung cancer other than small cell lung carcinoma (SCLC). Credit: Lung Cancer Research Foundation (LCRF).

  • Innovent Biologics

Go Top